Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.67% vs 11.51% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 2.26% vs 171.12% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 0.58% vs 431.96% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -17.88% vs 7.86% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Beijing Beilu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.67% vs 11.51% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.20% vs 6.83% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 2.26% vs 171.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 277.78% vs 169.23% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 0.58% vs 431.96% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 34.81% vs 126.47% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -17.88% vs 7.86% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -13.89% vs 11.63% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






